BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs3825942
,
PTEN
,
Response to oxidative stress
,
Leukemia
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mTORC2
Summary
General Info
Curated Studies
Most Correlated Studies
Glioblastoma U87-EGFRvIII cells with RICTOR siRNA knockdown
3T3 cell gene expression profiles in response to mTOR inhibition by rapamycin or PP242
Liver expression in RICTOR knockout mice fed after overnight fast
Regulatory T cells CD4+CD25+FOXP3+ from spleens and lymph nodes with PTEN conditional knockout
Kidney expression profiles in Raptor mutants before overt phenotype
Explore Curated Studies Results
Literature
Most Relevant Literature
Hepatic mTORC2 compensates for loss of adipose mTORC2 in mediating energy storage and glucose homeos…
The mTORC2 signaling network: targets and cross-talks.
Regulation of mTORC2 Signaling.
Ras-mediated activation of mTORC2 promotes breast epithelial cell migration and invasion.
mTORC2 contributes to systemic autoimmunity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastroz…
mTOR and Adipose Tissue Inflammation
Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High R…
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor …
Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacit…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ